Collaborations, Competitor News, Pharma

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders

Posted on

CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced it has extended its partnership with Takeda (TSE: 4502/NYSE: TAK) to diagnose patients with Lysosomal Storage Disorders (LSDs). Under the…

AI, Collaborations, Competitor News, Government/Regulatory

Cerner Enviza Collaborates with FDA to Develop Innovative AI Tools for Drug Safety and Real-World Evidence Studies

Posted on

FDA’s Sentinel Innovation Center chose Cerner Enviza and John Snow Labs for electronic health record and natural language processing expertise AUSTIN, Texas, April 10, 2023 /PRNewswire/ — Cerner Enviza, an Oracle company, along with John Snow Labs, are now helping support the U.S. Food and Drug Administration’s drug safety Sentinel Initiative. By developing artificial intelligence (AI) tools aimed…

Collaborations, Competitor News

Health Gorilla Partners With CLEAR to Empower Consumers to Securely Access and Control Their Health Information

Posted on

The partnership is a model for Health Information Exchanges nationwide to improve patient access and security MOUNTAIN VIEW, Calif. and NEW YORK, March 9, 2023 /PRNewswire/ — Health Gorilla, a leading Health Information Network and interoperability provider, has partnered with CLEAR, a secure identity verification platform, to launch Individual Access Services, which allows consumers…

Competitor News, Events, Marketing, RWE Study

ORIEN Researchers to Present Key Findings Utilizing M2GEN’s Avatar Data at AACR Annual Meeting

Posted on

Presentations highlight the utility of using real-world data to drive precision medicine forward TAMPA, Fla., April 7, 2023 /PRNewswire/ — M2GEN, an oncology-focused health informatics solutions company, today announced its participation as a presenter, exhibitor, and research partner at the American Association for Cancer Research (AACR) Annual Meeting April 14-19, in Orlando, Florida. Eight poster…

Government/Regulatory, Partner and Collaborator News

NIA set to build $300M ‘real world’ Alzheimer’s database

Posted on

The National Institute on Aging has set aside $300 million in grant money to kick-start the development of a centralized Alzheimer’s disease research database. The goal is to collect real-world data on Alzheimer’s disease in the United States, and create a platform that will serve as a central research hub, according…

Collaborations, Competitor News, Data Partnership, Pharma

PathAI and GlaxoSmithKline Sign Multi-Year Agreement to Accelerate Research and Drug Development

Posted on

BOSTON–(BUSINESS WIRE)–PathAI, a global leader in AI-powered pathology, and GlaxoSmithKline (GSK), today announced a strategic multi-year partnership to accelerate scientific research and drug development programs in oncology and non-alcoholic steatohepatitis (NASH) by leveraging PathAI’s technologies in digital pathology including the use of PathAI’s AIM-NASH tool. “Our partnership will combine GSK and…

Collaborations, Partner and Collaborator News

Palantir and Microsoft Expand Cloud Partnership to Public Sector

Posted on

DENVER, April 5, 2023 /PRNewswire/ — Palantir Technologies Inc. (NYSE: PLTR) today announced that Palantir Federal Cloud Service (PFCS) achieved FedRAMP authorization and accreditation to support workloads at U.S. Department of Defense (DoD) Impact Level (IL) 4 and DOD IL5 on Microsoft Azure. This new milestone enables U.S. government customers and industry partners…

Clinical Trials, Competitor News, Product Updates

ConcertAI Releases CTO 2.0, a Next Generation AI SaaS Solution for Oncology Clinical Trial Design and Optimization

Posted on

CAMBRIDGE, Mass., April 5, 2023 /PRNewswire/ — ConcertAI, LLC (ConcertAI), a leader in AI Software-as-a-Service (SaaS) technology and Real-world Evidence (RWE) solutions for life sciences and healthcare, today announced the release of its next generation of Clinical Trial Optimization (CTO 2.0). “Trial sponsors have a range of new imperatives they’re trying to…

AI, Competitor News, Product Updates

ConcertAI’s TeraRecon Brings Osteoarthritis and Fracture Detection to the Eureka Clinical AI Platform with Radiobotics Partnership

Posted on

Two applications for X-ray exams detect and analyze osteoarthritis in the knee, as well as fractures across the entire appendicular skeleton CAMBRIDGE, Mass., April 4, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, has partnered with Radiobotics to provide the state-of-the-art artificial intelligence and machine learning applications RBknee™ (FDA cleared and…

Collaborations, Competitor News, Europe, International, M&A

TriNetX and Clinerion Unite as TriNetX and Norstella Announce Strategic Partnership

Posted on

As part of the strategic partnership between Norstella and TriNetX, TriNetX will acquire Norstella’s Clinerion subsidiary.   CAMBRIDGE, Mass., April 4, 2023 /PRNewswire/ — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of novel therapies, and Norstella, the leading pharmaceutical solutions provider, today announced a multi-faceted…